HPBT
VRTX icon

Hickory Point Bank & Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

Hickory Point Bank & Trust’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.99K Hold
4
– – ﹤0.01% 415
2026
Q1 		$1.79K Buy
+4
New +$1.86K ﹤0.01% 427

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Hickory Point Bank & Trust's VRTX Position: Q2 2026 in Review

Hickory Point Bank & Trust held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 4 shares worth $1.99K. The position accounts for ﹤0.01% of the portfolio, ranked #415.

Hickory Point Bank & Trust first reported a position in VRTX in Q1 2026 and has held it in 2 quarters since. 733 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Hickory Point Bank & Trust held 4 shares of Vertex Pharmaceuticals worth $1.99K as of Q2 2026.
  • Hickory Point Bank & Trust left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of Hickory Point Bank & Trust's portfolio in Q2 2026, its #415 holding.
  • Hickory Point Bank & Trust first reported a position in Vertex Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 733 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Hickory Point Bank & Trust's 13F filing for Q2 2026, filed 17 Jul 2026.